Skip to content
Maui Sky – Lifestyle
Author:
Alector, Inc.
Alector Reports Third Quarter 2026 Financial Results and Provides Business Update
November 5, 2026
Alector Announces Pricing of Underwritten Offering
October 16, 2026
Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
October 7, 2026
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
October 5, 2026
Alector to Participate in Upcoming Healthcare Conferences
September 3, 2026
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026